Baker & Eastlack Ventures is a venture capital firm. The firm was founded by Kenneth D. Baker, MD FACS and Robert K. Eastlack, MD in 2016.
They focus on early-stage investment in medical technology and diagnostic sectors. They evaluate their investment from cost and time of clinical trials and market pricing and competitive advantage. Baker & Eastlock Ventures prefers 510K products and experienced management teams.